4.2 Article

Novel Blood Biomarkers Are Associated with White Matter Lesions in Fragile X-Associated Tremor/Ataxia Syndrome

期刊

NEURODEGENERATIVE DISEASES
卷 17, 期 1, 页码 22-30

出版社

KARGER
DOI: 10.1159/000446803

关键词

Fragile X-associated tremor/ataxia syndrome; Fragile X mental retardation 1 premutation; Cellular biomarkers; Mitochondrial respiration; Blood lymphoblasts; White matter hyperintensities

资金

  1. National Institutes of Child Health and Human Development [R01 HD 36071]
  2. La Trobe University Department of Microbiology
  3. School of Life Sciences
  4. 'Understanding Disease' Research Focus Area

向作者/读者索取更多资源

Background: The need for accessible cellular biomarkers of neurodegeneration in carriers of the fragile X mental retardation 1 (FMR1) premutation (PM) alleles. Objective: To assess the mitochondrial status and respiration in blood lymphoblasts from PM carriers manifesting the fragile X-associated tremor/ataxia syndrome (FXTAS) and non-FXTAS carriers, and their relationship with the brain white matter lesions. Methods: Oxygen consumption rates (OCR) and ATP synthesis using a Seahorse XF(e)24 Extracellular Flux Analyser, and steady-state parameters of mitochondrial function were assessed in cultured lymphoblasts from 16 PM males (including 11 FXTAS patients) and 9 matched controls. The regional white matter hyperintensity (WMH) scores were obtained from MRI. Results: Mitochondrial respiratory activity was significantly elevated in lymphoblasts from PM carriers compared with controls, with a 2- to 3-fold increase in basal and maximum OCR attributable to complex I activity, and ATP synthesis, accompanied by unaltered mitochondrial mass and membrane potential. The changes, which were more advanced in FXTAS patients, were significantly associated with the WMH scores in the supratentorial regions. Conclusion: The dramatic increase in mitochondrial activity in lymphoblasts from PM carriers may represent either the early stages of disease (specific alterations in short-lived blood cells) or an activation of the lymphocytes under pathological situations. These changes may provide early, convenient blood biomarkers of clinical involvements. (C) 2016 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据